FDA Import Refusal 845-2010265-2/1/1 — Xellia Pharmaceuticals ApS
The FDA refused shipment 845-2010265-2/1/1 from Xellia Pharmaceuticals ApS (Denmark) on March 11, 2004. The refused product falls under Drugs and Biologics — COLISTIN SULFATE (PEPTIDES). Cited charge: 2880 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 11, 2004
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 56FCS21 COLISTIN SULFATE (PEPTIDES)
- Charges
- 2880